Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge
Open Access
- 1 June 2020
- journal article
- research article
- Published by Wiley in ESC Heart Failure
- Vol. 7 (3), 1257-1263
- https://doi.org/10.1002/ehf2.12642
Abstract
Aims Congestive status, serum potassium, and renal function are major determinants of outcomes as well as critical elements for adjusting drug therapy in heart failure (HF) patients. This study aimed at describing the daily variations in estimated plasma volume (ePV, a surrogate of congestion computed from haemoglobin and haematocrit), blood potassium, and estimated glomerular filtration rate during 2 months post-hospitalization for decompensated HF with reduced ejection fraction. Methods and results The study was conducted in a single tertiary referral centre. Capillary blood samples were drawn by study nurses at home (7-12 am), and haematocrit, blood haemoglobin, creatinine, and potassium were measured using an approved home-based device (ABOTT i-STAT) (: NCT01655134). Among the 15 home-monitored patients, two patients died (one suddenly), and one was readmitted for ischaemic acute pulmonary oedema, with a subsequent acute coronary syndrome, and did not have a complete 2-month follow-up. The 5-day-a-week biological home monitoring revealed an ePV >5.5 mL/g Hb, suggestive of undiagnosed residual congestion at discharge in 3 out the 15 patients. It was possible to document a number of episodes of hyperkalaemia (>5: mean +/- standard deviation: 2.2 +/- 2.2 or 5.5: 1.7 +/- 1.6 mmol/L), hypokalaemia ( 20%: 1.3 +/- 1.8 or 30%: 0.7 +/- 1.2) and recongestion (ePV rise above 10%: 1.4 +/- 1.5, 15%: 2.3 +/- 2.4, 5.5 mL/g Hb: 1.8 +/- 2.6) episodes indicative of clinically relevant and potentially actionable cardiorenal and electrolytic patterns. Conclusions Our findings demonstrate that a 5-day-a-week home monitoring combining haemoglobin/haematocrit, potassium, and creatinine measurements was able to capture a substantial number of clinically relevant cardiorenal and electrolyte events which are frequently overlooked and potentially actionable. Whether acting on these events may help optimizing renin angiotensin aldosterone system inhibitors and diuretic therapy warrants further dedicated testing. The ongoing HERMES HF study (NCT04050904) is assessing the short-term feasibility and safety of such a monitoring strategy, complemented by a decision support system, and generating recommendations based on ESC clinical guidelines in patients discharged after an episode of worsening heart failure with reduced ejection fraction.Keywords
This publication has 21 references indexed in Scilit:
- Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart FailureJAMA, 2015
- Prognostic Value of Estimated Plasma Volume in Heart FailureJACC: Heart Failure, 2015
- Evaluation of the i-STAT point-of-care capillary whole blood hematocrit and hemoglobin: Comparison to the Siemens RAPIDLab 1200, Sysmex XE5000, and manual spun hematocritClinica Chimica Acta; International Journal of Clinical Chemistry, 2015
- Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trialsEuropean Journal of Heart Failure, 2015
- Haemoconcentration, renal function, and post‐discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trialEuropean Journal of Heart Failure, 2013
- Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing EffectsJournal of the American College of Cardiology, 2011
- Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and SurvivalCirculation, 2010
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention.Heart, 1994